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Introduction {#sec1}
============

Two key requirements for the success of multicellular life are the ability of cells to adhere to each other, via a secreted protein network called the extracellular matrix (ECM), and to communicate with each other, sometimes over long distances, through the release of signaling molecules. In addition to providing structural support to tissues, the ECM has evolved to regulate intercellular signaling pathways, for example by binding to growth factors and regulating their distribution or activity in the extracellular space ([@bib8]). The ECM can also signal through its own adhesion receptors, primarily integrins, to initiate intracellular signaling events that converge with growth factor signaling pathways, thus allowing cells to integrate information about ECM composition and mechanical properties with biochemical signals ([@bib6]).

Although crosstalk between integrin signaling and growth-factor-activated receptor tyrosine kinase signaling has been studied in some detail ([@bib1]), comparably little is known about how the ECM influences intracellular signaling through bone morphogenetic proteins (BMPs), a highly conserved family of growth factors with diverse roles during development and disease ([@bib28]). In the canonical signaling pathway, BMPs assemble complexes of type I and type II receptors, leading to activation of the type I receptor Ser/Thr kinase domain and phosphorylation of a Smad transcription factor (Mad in *Drosophila*) ([@bib28]). Phospho-Mad (pMad) associates with a second Smad transcription factor (Medea in *Drosophila*), and the pMad/Medea complex accumulates in the nucleus to regulate transcription of BMP target genes. Using the *Drosophila* model, we have recently shown that the ECM molecule collagen IV directly binds BMPs and regulates their movement across tissues ([@bib20; @bib26]). Several findings indicate that collagen IV may also act locally to enhance BMP signal reception. For example, collagen IV is required for local activation of BMP signaling at the tip of developing renal tubules ([@bib4]). Furthermore, collagen IV can enhance the effect of BMPs in tissue culture, where long-range movement is unlikely to be important ([@bib18]).

To understand how the local ECM environment impacts BMP responses, we investigated a role for integrins, which are collagen IV receptors ([@bib9]). We find that maximal levels of BMP pathway activation in vivo are only achieved in the presence of integrin signaling, which functions downstream of collagen IV to potentiate signaling through the canonical Smad pathway.

Results {#sec2}
=======

Integrins Are Required for Peak Levels of BMP Signaling in the Early *Drosophila* Embryo {#sec2.1}
----------------------------------------------------------------------------------------

We examined a role for integrins in BMP pathway activation in the early *Drosophila* embryo, where a BMP activity gradient specifies cell fates along the dorsoventral axis ([Figure 1](#fig1){ref-type="fig"}A). Integrin receptors are expressed on the cell surface as α/β heterodimers ([@bib12]). As βPS is the only β-integrin expressed in the early blastoderm embryo ([Figure S1](#mmc1){ref-type="supplementary-material"}A), we induced homozygous germline clones for a null allele of βPS, *mys*^*XG43*^ ([@bib12]), and analyzed BMP target gene expression in embryos lacking maternal and zygotic βPS expression and therefore all integrin function (from now on referred to as *βPS*^*−*^ embryos). In wild-type embryos, the high threshold BMP target genes *Race* (*Ance* in FlyBase) and *hindsight* (*hnt*) are expressed in a narrow stripe along the dorsal midline (presumptive amnioserosa), where peak signaling occurs, while the lower threshold gene *u-shaped* (*ush*) is expressed in a broader dorsal domain ([Figure 1](#fig1){ref-type="fig"}B). By contrast, in *βPS*^*−*^ embryos, *Race* and *hnt* expression is lost in the presumptive amnioserosa, and *ush* expression is significantly (p \< 0.0001) narrower ([Figure 1](#fig1){ref-type="fig"}B), characteristic of embryos with reduced levels of BMP signaling. The BMP defect is rescued by a paternal wild-type copy of *βPS* (data not shown). Expression of the major BMP ligand in the early embryo, *dpp*, and of *sog*, which encodes a critical extracellular BMP regulator ([@bib28]), is unaffected in *βPS*^*−*^ embryos ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Together, these data indicate that integrins are required for normal levels of BMP signaling in the early embryo.

As βPS can form receptors with several α-integrins ([@bib3]), we examined BMP phenotypes in α-integrin mutant embryos. Out of the five α-integrin genes, we found that *multiple edematous wings* (*mew*) and *scab* (*scb*) are expressed in partially overlapping domains in the dorsal ectoderm ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C), where BMP signaling is active. In addition, *mew* expression extends ventrally into the neuroectoderm, overlapping with the expression domain of *sog* ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Embryos mutant for *mew* or *scb* exhibit defects in the expression of BMP target genes ([Figure 1](#fig1){ref-type="fig"}C), with differences in the phenotypes for *mew* and *scb* mutants reflecting their different expression patterns in the embryo. For *Race*, the expression is preferentially lost in the posterior in *scb* mutant embryos, whereas it is lost uniformly along the anterior-posterior axis in *mew* mutants (compare embryos classified as "weak" in [Figure 1](#fig1){ref-type="fig"}C). These results suggest that integrin receptors involving both *mew* and *scb* gene products enhance BMP signaling in the early embryo. The posteriorly expressed target gene *hnt*, like *Race*, is partially or fully lost in the *scb* mutant but infrequently lost in *mew* mutants ([Figure 1](#fig1){ref-type="fig"}C). Also, in a subset of *mew* mutants, *Race*, *hnt*, or *ush* expression is broadened, in extreme cases resembling embryos that lack Sog ([Figures 1](#fig1){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}C). This likely represents a function of *mew* in regulating Sog distribution, as previously described in the developing wing ([@bib2]), in addition to its integrin signaling function described below. This second function may lead to a slightly flatter BMP gradient in *mew* mutants, thus explaining the broader *hnt* expression observed ([Figure 1](#fig1){ref-type="fig"}C), in contrast to the loss of *Race*, a gene that is absolutely dependent on the highest BMP levels.

We next quantified the pMad gradient in *βPS*^*−*^ embryos ([@bib24]) To circumvent staining variability between samples, we only compared *βPS*^*−*^ embryos to siblings that were maternal *βPS*^*−*^ zygotic *βPS*^+^, as these embryos could be processed together throughout. Maternal *βPS*^*−*^ zygotic *βPS*^+^ embryos show no defect in BMP target gene expression or pMad activation ([Figure 1](#fig1){ref-type="fig"}D; data not shown), making them a valid control. In both *βPS*^*−*^ and control embryos, peak pMad levels increase markedly between stage 5 and stage 6 ([Figure 1](#fig1){ref-type="fig"}E), consistent with previous reports of pMad gradient dynamics ([@bib19]). At stage 5, pMad levels are considerably lower in *βPS*^*−*^ embryos than controls, resulting in a narrower gradient and a reduced peak ([Figure 1](#fig1){ref-type="fig"}E). At stage 6, peak pMad levels at the dorsal midline reach similar levels in *βPS*^*−*^ and control embryos ([Figure 1](#fig1){ref-type="fig"}E); however, the dorsal domains over which the gradient reaches a threshold of 0.4 and 0.6 are significantly narrower ([Figures 1](#fig1){ref-type="fig"}F and 1G). In wild-type embryos, these thresholds correspond to the width of *ush* (∼14 cells; see [Figure 1](#fig1){ref-type="fig"}A) and *Race*/*hnt* (four to six cells; see [Figure 3](#fig3){ref-type="fig"}D) expression, respectively, consistent with the reduction in pMad levels leading to disrupted BMP target gene expression in *βPS*^*−*^ embryos. Although we cannot rule out additional effects on non-canonical BMP signal transduction or BMP-independent effects, our data demonstrate that integrins are required for the timely and robust formation of the pMad gradient in the early embryo.

The Signaling Function of Integrins Is Sufficient for Their Role in BMP Pathway Activation {#sec2.2}
------------------------------------------------------------------------------------------

To test if integrins exert their effect on BMP signaling through their extracellular ligand binding activity or by activating intracellular signaling pathways, we made use of a chimeric receptor, Torso^D^βPS~cyt~, in which the cytoplasmic domain of βPS is fused to the transmembrane and extracellular domains of a constitutively active form of the Torso receptor ([@bib14]). This integrin signaling construct is unable to bind integrin ligands, but it is capable of signaling due to Torso^D^-mediated clustering of the βPS cytoplasmic domain ([Figure 2](#fig2){ref-type="fig"}A). We used the Gal4/UAS-system to express wild-type βPS or Torso^D^βPS~cyt~ transgenes in *βPS*^*−*^ embryos and tested for their ability to rescue the BMP phenotype. Zygotic expression of wild-type βPS restores *Race* expression in ∼50% of embryos ([Figure 2](#fig2){ref-type="fig"}B). Rescue in only half of the embryos likely reflects the proportion expressing the Gal4 transcription factor maternally and zygotically, as opposed to maternally only. The Torso^D^βPS~cyt~ integrin signaling construct was also able to rescue *Race* and *hnt* induction in *βPS*^*−*^ embryos ([Figures 2](#fig2){ref-type="fig"}B and 2C), demonstrating that the signaling function of integrins is sufficient for their role in promoting BMP signaling. Overexpression of βPS or Torso^D^βPS~cyt~ in a wild-type background does not broaden *Race* or *hnt* expression ([Figure S3](#mmc1){ref-type="supplementary-material"}), suggesting that whereas integrin signaling is required to augment BMP signaling, it is not limiting with respect to this function in a wild-type context. We conclude that integrin signaling is permissive for generating peak levels of BMP pathway activation.

Integrin Signaling Acts Downstream of Collagen IV to Enhance BMP Activity {#sec2.3}
-------------------------------------------------------------------------

We have shown previously that collagen IV mutant embryos have disrupted BMP signaling due to an altered extracellular BMP distribution ([@bib26]). If collagen IV acts as an integrin ligand, a loss of integrin signaling may contribute to the defect in BMP signaling observed in collagen IV mutant embryos ([Figure 3](#fig3){ref-type="fig"}A). To test this, we examined whether Torso^D^βPS~cyt~, which induces integrin signaling independent of ECM ligands, can rescue BMP target gene expression in embryos with reduced levels of collagen IV ([Figure 3](#fig3){ref-type="fig"}A), due to a mutation in *viking*, one of two collagen IV genes in *Drosophila* ([@bib26]). As shown in [Figure 3](#fig3){ref-type="fig"}B, overexpression of Torso^D^βPS~cyt~ restores *Race* induction in ∼50% of embryos, whereas wild-type βPS, which requires an ECM ligand for activation of signaling, has no effect. This result suggests that integrin signaling may act downstream of collagen IV to enhance BMP activity. The partial rescue of *Race* expression observed with Torso^D^βPS~cyt~ in collagen IV mutant embryos, as compared to *βPS*^*−*^ embryos ([Figure 2](#fig2){ref-type="fig"}B), is consistent with a dual role for collagen IV in promoting BMP signaling in the early embryo: to activate integrin signaling and promote extracellular BMP gradient formation ([@bib20; @bib26]). In agreement with this, a reduction in collagen IV leads to a more severe decrease in BMP signaling than the loss of integrins, based on the width of *ush* expression ([Figure 3](#fig3){ref-type="fig"}C).

To exclude the possibility that the loss of integrin signaling in collagen IV mutants is due to a general loss of ECM integrity, we examined BMP signaling in embryos lacking expression of laminin, an ECM protein that interacts with the collagen IV network and can act as an integrin ligand in *Drosophila* ([@bib3]). In contrast to integrin and collagen IV mutants, embryos lacking β-laminin show a variable expansion of the *Race* expression domain ([Figure 3](#fig3){ref-type="fig"}D). We speculate that this expanded *Race* expression is due to competition between collagen IV and laminin for binding to integrins, with only collagen IV interactions leading to BMP-promoting signaling events. In support of this, we find that addition of laminin to *Drosophila* cells plated on a collagen IV substrate, but not when plated on plastic, inhibits pMad accumulation in a dose-dependent manner following pathway stimulation, and this effect is reduced by co-transfecting additional βPS ([Figure 3](#fig3){ref-type="fig"}E, right panel). Together, these results suggest that engagement of integrin receptors by collagen IV, but not laminin, promotes BMP responses in the early *Drosophila* embryo.

Integrin Signaling Acts Downstream of BMP Receptor Activation to Enhance pMad Accumulation {#sec2.4}
------------------------------------------------------------------------------------------

We next investigated the molecular link between integrin signaling and enhanced BMP signal transduction. A key signaling protein linking integrin to growth factor pathways is focal adhesion kinase (FAK) ([@bib6]). However, we did not detect any defect in BMP signaling in embryos lacking *Drosophila* FAK ([Figure S4](#mmc1){ref-type="supplementary-material"}A), suggesting that integrin signaling enhances BMP signal transduction through an FAK-independent mechanism.

To further dissect this mechanism, we developed a *Drosophila* tissue culture assay. Treatment of S2R+ cells with the BMP ligand Dpp induces pMad, and this is enhanced when cells are plated on collagen IV ([Figure 4](#fig4){ref-type="fig"}A). RNAi-mediated knockdown of βPS abolishes the stimulatory effect of collagen IV on pMad induction, whereas it has no effect on pMad levels in plastic-plated cells ([Figures 4](#fig4){ref-type="fig"}A and 4C). As shown in [Figures 4](#fig4){ref-type="fig"}B and 4C, βPS RNAi in collagen IV-plated cells also reduces pMad induction by a constitutively active form of the BMP receptor Thickveins (Tkv), Tkv^QD^, indicating that collagen IV/integrin signaling acts downstream of Tkv activation. The effects of collagen IV/integrins on pMad levels do not coincide with changes in the levels of total Mad (transfected Flag-Mad) ([Figures 4](#fig4){ref-type="fig"}A and 4B), suggesting that they are not mediated via an effect on Mad stability. In terms of the α-integrin requirement, knockdown of both *mew* and *scb* together, but not either subunit alone, also reduces pMad accumulation ([Figure 4](#fig4){ref-type="fig"}D), suggesting that both α-integrins can function with βPS to stimulate pMad.

Consistent with our in vivo rescue experiments ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}), the positive effect of collagen IV/integrins on both Dpp- or Tkv^QD^-induced pMad accumulation can be mimicked by expression of Torso^D^βPS~cyt~ ([Figures 4](#fig4){ref-type="fig"}E and 4F), confirming that integrin signaling mediates the effect on pMad observed in S2R+ cells and demonstrating that integrin signaling acts cell autonomously to enhance BMP responses. We next used the Torso^D^βPS~cyt~ construct to identify residues in the βPS cytoplasmic domain required for integrin-enhanced pMad accumulation. Two conserved NPXY motifs in the β-integrin cytoplasmic tail are important for the recruitment of a variety of integrin-binding proteins ([@bib11]). Mutation of tyrosine in the first (Y831) or second (Y843) NPXY motif to alanine, either alone or in combination, did not affect expression levels of Torso^D^βPS~cyt~ ([Figure 4](#fig4){ref-type="fig"}F) but compromised its ability to promote pMad phosphorylation ([Figure 4](#fig4){ref-type="fig"}F). These results suggest that both NPXY motifs in the βPS cytoplasmic tail are important for its enhancement of BMP signaling.

To gain further mechanistic insight, we tested if integrin receptors interact with Tkv. Indeed, we found that Tkv, but not a control transmembrane protein (Frizzled), can co-immunoprecipitate with βPS, *mew* (αPS1) and *scb* (αPS3) ([Figures 4](#fig4){ref-type="fig"}G--4I). The interaction between αPS1 or αPS3 and Tkv is abrogated by βPS RNAi ([Figures 4](#fig4){ref-type="fig"}H and 4I), consistent with integrin surface presentation being dependent on functional integrin receptors ([@bib12]). We next truncated the βPS cytoplasmic tail after residues involved in stabilization of the integrin α-β heterodimer ([Figure S4](#mmc1){ref-type="supplementary-material"}B). A similar truncation in mammalian β3 integrin does not disrupt cell-surface expression ([@bib17]), a result we confirmed for our βPS-trunc construct ([Figure S4](#mmc1){ref-type="supplementary-material"}C). As shown in [Figure 4](#fig4){ref-type="fig"}J, truncation of the βPS cytoplasmic tail abrogates the interaction with Tkv, suggesting that the integrin-Tkv interaction is mediated intracellularly and therefore could be relevant for the integrin-mediated enhancement of Tkv-mediated Mad phosphorylation. By contrast, mutation of the NPXY motifs in the βPS did not impair its binding to Tkv ([Figure 4](#fig4){ref-type="fig"}J). As the NPXY motifs are required for integrin-signaling mediated enhancement of pMad ([Figure 4](#fig4){ref-type="fig"}F), this suggests that binding of integrins to Tkv alone is not sufficient to enhance pMad accumulation (see [Discussion](#sec3){ref-type="sec"}). Together, our data suggest that integrin receptors can form complexes with BMP receptors, enhancing their ability to phosphorylate Mad.

The α-Integrin Subunit scb/αPS3 Is Itself a BMP Target Gene {#sec2.5}
-----------------------------------------------------------

The spatial and temporal expression pattern of *scb* is consistent with this α-integrin encoding gene being positively regulated by BMP signaling. Therefore we examined the *scb* expression pattern in embryos with increased and decreased levels of BMP signaling. We found that *scb* expression is expanded ventrally in embryos with four copies of *dpp* or overexpressing the activated BMP receptor, *tkv*^*QD*^, and lost in *dpp*^*Hin37*^ mutant embryos ([Figure 5](#fig5){ref-type="fig"}A). The lack of *scb* expression in the central region of the embryo can be explained at least in part by a repressive input from the gap gene transcription factor Krüppel, as *scb* expression expands into the central region in *Krüppel* mutant embryos ([Figure S5](#mmc1){ref-type="supplementary-material"}). Overall, these data demonstrate that *scb* is indeed a BMP target gene and identify a positive feedback loop in which BMP-dependent induction of *scb* expression further enhances BMP signal transduction via the activation of integrin signaling.

Discussion {#sec3}
==========

Our study reveals that BMP-responsive transcription during *Drosophila* embryonic dorsal-ventral axis patterning is not simply a readout of the BMP signal but instead requires synergy between BMP and integrin signaling. Our data support a model whereby collagen IV activation of integrin signaling augments pMad levels ([Figure 5](#fig5){ref-type="fig"}B). Consistent with collagen IV acting as an integrin ligand, which is well documented in vertebrates ([@bib9]), collagen-IV-directed rotations of follicle epithelia during *Drosophila* oogenesis also require integrins ([@bib7]). Thus, we envisage two functions for collagen IV in regulating BMP signaling ([Figure 5](#fig5){ref-type="fig"}B): (1) collagen IV shapes the BMP gradient through a direct collagen IV-Dpp interaction, as we have described previously ([@bib20; @bib26]); and (2) collagen IV activates integrin signaling, which amplifies the BMP signal by forming complexes with BMP receptors and enhancing induction of pMad. In addition, we show specificity for collagen-IV-induced integrin activation, as laminin, which can bind both αPS1- and αPS3-containing integrin receptors ([@bib3; @bib21]), does not promote BMP responses, possibly due to activation of a distinct signaling complex that does not increase pMad. Instead, our data support competition between collagen IV and laminin for integrin binding, suggesting that the relative levels of laminin, collagen IV, and integrins in a particular developmental context will impact the extent of BMP pathway activation.

Mechanism of Integrin-Enhanced BMP Signal Transduction {#sec3.1}
------------------------------------------------------

Our data indicate that collagen IV/integrin signaling in the early embryo promotes activation of canonical Smad-dependent signal transduction in a mechanism that is independent of FAK but may involve an association of integrins and BMP receptors. Several recent studies have also reported interactions between integrins and BMP receptors, leading to inhibition of Smad phosphorylation ([@bib16]) or enhanced Smad phosphorylation either via a BMP-ligand-independent, shear-stress-induced activation of FAK/ERK MAPK signaling ([@bib29]) or via extracellular domain interactions that increase the ligand binding affinity of the BMP receptor ([@bib23]). Our data show that collagen IV/integrin signaling enhances pMad levels via a distinct mechanism, as it is independent of FAK and involves intracellular domain interactions downstream of BMP receptor activation.

We identify two conserved NPXY motifs in the βPS cytoplasmic domain as important sites for integrin-BMP synergy, but these motifs are not required for βPS binding to Tkv, suggesting that binding of integrins to BMP receptors is not sufficient for promoting Mad phosphorylation. One possibility is that the NPXY motifs are required for the recruitment of factors that facilitate or stabilize Mad phosphorylation. NPXY motifs are also involved in regulating the endocytosis and recycling of integrin receptors ([@bib13]). As some evidence suggests that Smad phosphorylation by BMP receptors occurs preferentially on endosomes ([@bib22]), integrin-facilitated endocytosis and/or recycling of BMP receptors could enhance Mad phosphorylation.

Roles of αPS1/mew and αPS3/scb in Integrin-Mediated Enhancement of BMP Signaling {#sec3.2}
--------------------------------------------------------------------------------

Previously, integrins have been implicated in regulating Sog distribution in ovarian follicle cells and the pupal wing ([@bib2; @bib15]). Although the low penetrance *sog* mutant-like phenotype we observed in *mew* mutant embryos is also consistent with a function of *mew*/αPS1 in modulating Sog levels ([Figure 5](#fig5){ref-type="fig"}B), the major role of integrins in the early embryo appears to involve their signaling function, as we can rescue the integrin-null phenotype with the Torso^D^βPS~cyt~ signaling-activated transgene. Consistent with this, our RNAi knockdown data suggest that integrin signaling through both αPS1 and αPS3 can promote Tkv-mediated Mad phosphorylation and both αPS1 and αPS3 bind Tkv. In the early embryo, due to their different expression patterns and their distinct additional roles of promoting Sog function (αPS1) or providing positive feedback on BMP signaling (αPS3), we expect αPS1 and αPS3 to act only partially redundantly. Indeed, we observe disrupted BMP target gene expression in *mew* and *scb* single mutants, with distinct spatial pattern of *Race* defects. As BMP target gene expression in the central region of the embryo (expressing only αPS1) is more sensitive than the regions in the anterior and posterior (expressing both αPS1 and αPS3) to genetic perturbations, such as overexpression of Sog ([@bib27]), we speculate that integrin signaling through both αPS1 and αPS3 may contribute to robustness of the pMad gradient in vivo.

Integrin Signaling as a Positive Feedback Loop for BMP Activity {#sec3.3}
---------------------------------------------------------------

Our data reveal that expression of *scb* is induced by BMP signaling in the early embryo, identifying a positive feedback loop in which activation of *scb* allows integrin signaling, which further increases BMP responses at the dorsal midline. Positive feedback, involving a transcriptional mechanism, has previously been implicated in the conversion of the BMP activity gradient into a spatially bistable pattern of gene expression that subdivides the dorsal ectoderm into distinct tissues ([@bib25]). Recently, the tumor necrosis factor α ligand *eiger* has been identified in the positive feedback circuit, but additional genes are thought to be involved ([@bib5]). *scb* may represent such an additional BMP target gene.

In summary, our findings reveal that interpretation of the BMP embryonic morphogen gradient requires not only a response to the extracellular BMP concentration but also integrin-mediated enhancement through positive feedback and integration of context-specific information from the ECM. We predict that the integrin-BMP synergy identified here may have wide-ranging implications during other development or disease contexts where the functions of BMPs, collagen IV, and integrins converge, such as stem cell fate decisions or angiogenesis.

Experimental Procedures {#sec4}
=======================

Fly Strains, Crosses, Embryo Collection, and Phenotype Analysis {#sec4.1}
---------------------------------------------------------------

Embryos were collected, aged, and fixed with formaldehyde using standard procedures. Details of fly strains, crosses, and phenotype analysis are provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

RNA In Situ Hybridization and Immunostaining {#sec4.2}
--------------------------------------------

RNA in situ hybridizations were performed using digoxigenin-UTP-labeled exonic RNA probes. Fluorescent RNA in situ hybridizations were performed as previously described ([@bib10]) using digoxigenin-UTP-labeled probes for exon 5 of *mew* and full-length *sog* and a biotin-UTP-labeled probe for exon 3 of *scb*. Antibodies used were sheep anti-digoxigenin (1:400, Roche), mouse anti-biotin (1:400, Invitrogen), donkey anti-mouse-immunoglobulin G (IgG)-Alexa 488 (1:500, Invitrogen), and donkey anti-sheep-IgG-Alexa 555 (1:500, Invitrogen). For immunostaining, antibodies used were rabbit anti-pMad (1:250, gift from P. ten Dijke), chicken anti-β-Gal (1:1,000, Abcam), anti-rabbit-IgG-Alexa 594 (1:400, Invitrogen), and anti-chicken-IgG-488 (1:400, Invitrogen). Immunostained embryos were mounted in Prolong (Invitrogen). Detailed protocols are available on request. For details of pMad quantification, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

*Drosophila* S2 Cell Culture Experiments {#sec4.3}
----------------------------------------

*Drosophila* S2R+ cells were cultured at 25°C in insect medium (PAA Laboratories) with 10% FBS (PAA Laboratories) and 1% penicillin/streptomycin, plated on human collagen IV or plastic, and transiently transfected using Effectene (QIAGEN). Where appropriate, expression was induced with 500 μΜ CuSO~4~ 24 hr post-transfection. Cells were harvested 72h after transfection or Cu-induction and lysed in NP40 buffer (150 nM NaCl, 20 mM Tris-Cl \[pH 8\], 1% NP-40, EDTA, 0.1% protease and phosphatase inhibitor) for SDS-PAGE/western blotting. For RNAi treatment, cells were serum-starved for 1 hr and treated with 10 μg/ml double-stranded RNA for 2 hr at 25°C, then 10% FBS was added to the medium. For stimulation with Dpp, transfected cells were serum-starved for 1 hr, followed by addition of 3 nM recombinant Dpp (rDpp) (R&D Systems) for 2 hr before lysis. Protein bands were quantified using Li-COR Imager (Li-COR Biosciences) and ImageJ. For details of DNA transfections, collagen IV plating, laminin competition, co-immunoprecipitation, and immunofluorescence experiments, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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![Loss of Integrin Expression Causes Defects in BMP Signaling Responses in the Early Embryo\
(A) Early *Drosophila* embryo showing patterning of the dorsal ectoderm by a gradient of BMP activity.\
(B) RNA in situ hybridizations of wild-type or maternal/zygotic *mys*^*XG43*^ mutant (*βPS*^*−*^) embryos showing expression of the BMP target genes *Race*, *hnt*, and *ush*. For *Race* and *hnt* quantification, n = 3, \>15 embryos per genotype in each experiment; error bars represent SEM. For *ush* width, individual measurements are shown with mean ± SD (n = 92 for wild-type and n = 69 for *βPS*^*−*^). ^∗∗∗∗^p \< 0.0001 (unpaired t test).\
(C) RNA in situ hybridizations for *Race* and *hnt* in *mew (mew*^*M6*^) and *scb* (*scb*^*5J38*^) mutant embryos. Phenotypes were classified as "lost," "weak," or "broad" (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} and [Figure S2](#mmc1){ref-type="supplementary-material"}B for details) and were counted on embryo samples collected from heterozygous mutant stocks (n = 3, \>60 embryos counted per genotype in each experiment; error bars represent SEM).\
(D) pMad immunostaining of wild-type, maternal *βPS*^*−*^ zygotic *βPS*^*+*^ (mat *βPS*^*−*^ zyg *βPS*^*+*^) and maternal/zygotic *βPS*^*−*^ (*βPS*^*−*^) embryos. All scale bars represent 50 μm.\
(E--G) Quantification of the pMad gradient in mat *βPS*^*−*^, zyg *βPS*^*+*^, and *βPS*^*−*^ embryos. (E) Mean pMad intensity along the dorsal-ventral axis at 0.5 embryo length. Threshold lines indicate the width of the pMad gradient plotted in (C) and (D). (F and G) Mean width of the pMad gradient at thresholds 0.4 (C) and 0.6 (D) along the anterior-posterior axis for stage 6 embryos. Black dots indicate significant differences (p \< 0.05) between maternal *βPS*^*−*^ zyg *βPS*^*+*^ and *βPS*^*−*^.\
All embryo images show dorsal views of stage 6 embryos, anterior to the left. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Integrin Signaling Is Sufficient to Rescue the BMP Phenotype in *βPS*^*−*^ Integrin Mutant Embryos\
(A) Torso^D^βPS~cyt~ construct, which can mimic integrin signaling in the absence of ligand binding.\
(B and C) Overexpression of βPS and of Torso^D^βPS~cyt~ in maternal/zygotic *mys*^*XG43*^ mutant (*βPS*^*−*^) embryos can rescue expression of the peak threshold BMP target genes *Race* (B) and *hnt* (C). Rescue was quantified as the percentage increase in embryos with a wild-type expression pattern relative to a no transgene control (n = 3, \> 50 embryos counted per genotype in each experiment; error bars are SEM). For details, see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. Asterisks denote significant difference from no transgene control (i.e., 0% rescue); ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001 (t test). Scale bars represent 50 μm.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Activation of Integrin Signaling Can Partially Restore BMP Signaling Defects in Collagen IV Mutant Embryos\
(A) Diagram showing how a potential loss of integrin signaling in collagen IV mutant embryos may reduce BMP signaling (left), which would be predicted to be rescued by constitutively active integrin signaling (right).\
(B) Expression of Torso^D^βPS~cyt~, but not wild-type βPS, can partially restore expression of *Race* in collagen IV (*viking*) mutant embryos. *Race* expression patterns were classified as normal, weak, or lost (n = 3, \>70 embryos counted per genotype in each experiment; error bars represent SEM). Asterisks denote significant difference from no transgene control (i.e., 0% rescue); ^∗^p \< 0.05 (t test). See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for details of rescue quantification.\
(C) The *ush* expression pattern is narrower in collagen IV (*viking*) mutant embryos than in embryos lacking β integrin (*βPS*^*−*^). *ush* width shown as individual measurements and mean ± SD, n \> 45 for each genotype; ^∗∗∗∗^p \< 0.0001 (ordinary one-way ANOVA).\
(D) Maternal/zygotic *LanB1*^*1B1*^ mutant embryos show a broadened *Race* expression pattern. *Race* width shown as individual measurements and mean ± SD, n \> 35 for each genotype; ^∗∗∗∗^p \< 0.0001 (Welch's test). Scale bars represent 50 μm.\
(E) Western blot of pMad and transfected Flag-Mad (total Mad), Flag-Tkv^QD^, and Myc-βPS in S2R+ cells which were plated on either plastic or collagen IV and treated with increasing levels of laminin, as indicated.](gr3){#fig3}

![Molecular Mechanism of Integrin-Signaling-Mediated Enhancement of the BMP Pathway\
(A) Western blot for Flag-Mad, pMad, and tubulin in S2R+ cells transfected with Flag-Mad, which were plated on either plastic or collagen IV and treated with rDpp and βPS RNAi, as indicated.\
(B) Western blot for Flag-Mad, pMad, Flag-Tkv^QD^, βPS, and tubulin in cells transfected with Flag-Mad and plated on collagen IV. BMP signaling was activated by co-transfection of Flag-Tkv^QD^ or treatment with rDpp, and cells were treated with βPS RNAi as indicated.\
(C) Quantification of the experiments in (A) and (B), showing fold reduction in pMad activation by βPS RNAi on plastic- or collagen-IV-plated cells. pMad levels were normalized to total Mad (Flag-Mad) in each sample. n = 3--6; ^∗∗∗^p \< 0.001 (one-way ANOVA).\
(D) Western blot as described in (B) with quantitation, but cells were also treated with αPS1 and/or αPS3 RNAi.\
(E) Western blot for Flag-Mad, pMad, Flag-Tkv^QD^, and Myc-Torso^D^βPS~cyt~ in cells transfected with Flag-Mad, Flag-Tkv^QD^, and Myc-Torso^D^βPS~cyt~ and plated on plastic.\
(F) As in (E), except cells were transfected with Flag-Mad and Myc-tagged wild-type or mutant Torso^D^βPS~cyt~, and treated with rDpp. Quantitation shows increase in pMad (n = 4); ^∗^p \< 0.05, ^∗∗^p \< 0.001 (paired t tests).\
(G--I) Co-immunoprecipitation experiments between Flag-Tkv^QD^ and the βPS (G), αPS1 (H), and αPS3 (I) integrin subunits. Frizzled is a negative control.\
(J) Co-immunoprecipitation between Flag-Tkv^QD^ and Myc-βPS forms with truncation of the cytoplasmic tail or both NPXY motifs mutated.\
All error bars show SEM. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![A Positive Feedback Loop Potentiates Integrin-BMP Synergy\
(A) RNA in situ hybridizations for *scb* in wild-type embryos and in embryos with altered levels of BMP signaling. Scale bars represent 50 μm.\
(B) Model of integrin-BMP synergy. See [Discussion](#sec3){ref-type="sec"} for details.\
See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

[^1]: Present address: The Francis Crick Institute, Mill Hill Laboratory, The Ridgeway, London NW7 1AA, UK
